I didn’t realise Akida 2.0 hadn’t been released yet. Companies putting on hold their expenditure until then seems logical and prudent. Certainly explains the low revenue.
Not sure what people expected, the technology and potential remains wild.
It’s always been a hero or zero play in my mind. The only difference is now we won’t know until the evaluation of Akida 2.0. If it truly addresses the potential users’ needs then bingo. If not, dust.
But plenty of articles describing real use cases so I remain optimistic of a Pantene outcome in coming years.
Ann: Appendix 4D and 1H23 Financial Report, page-15
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $483.2M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 25.0¢ | 23.0¢ | $2.383M | 9.852M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 338128 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 1301709 | 24 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| BRN (ASX) Chart |